This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Jan 18;111(2):230-9.

doi: 10.1161/01.CIR.0000151805.86933.35.

Drug therapy in the heart transplant recipient: part IV: drug-drug interactions

Robert L Page 2nd¹, Geraldine G Miller, JoAnn Lindenfeld

Affiliations

PMID: 15657387
DOI: 10.1161/01.CIR.0000151805.86933.35

Review

Drug therapy in the heart transplant recipient: part IV: drug-drug interactions

Robert L Page 2nd et al. Circulation. 2005.

. 2005 Jan 18;111(2):230-9.

doi: 10.1161/01.CIR.0000151805.86933.35.

Authors

Robert L Page 2nd¹, Geraldine G Miller, JoAnn Lindenfeld

Affiliation

¹ Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver, Colo 80262, USA.

PMID: 15657387
DOI: 10.1161/01.CIR.0000151805.86933.35

No abstract available

PubMed Disclaimer

Similar articles

[Drug metabolism and drug interaction of anxiolytics].
Uchimura N, Etou Y. Uchimura N, et al. Ryoikibetsu Shokogun Shirizu. 2003;(38):612-6. Ryoikibetsu Shokogun Shirizu. 2003. PMID: 12877062 Review. Japanese. No abstract available.
Drug therapy in the heart transplant recipient: Part III: common medical problems.
Lindenfeld J, Page RL 2nd, Zolty R, Shakar SF, Levi M, Lowes B, Wolfel EE, Miller GG. Lindenfeld J, et al. Circulation. 2005 Jan 4;111(1):113-7. doi: 10.1161/01.CIR.0000151609.60618.3C. Circulation. 2005. PMID: 15630040 Review. No abstract available.
Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.
Elbarbry FA, Marfleet T, Shoker AS. Elbarbry FA, et al. Transplantation. 2008 May 15;85(9):1222-9. doi: 10.1097/TP.0b013e31816fc03b. Transplantation. 2008. PMID: 18475175 Review.
Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs.
Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J. Lindenfeld J, et al. Circulation. 2004 Dec 14;110(24):3734-40. doi: 10.1161/01.CIR.0000149745.83186.89. Circulation. 2004. PMID: 15596559 Review. No abstract available.
Pharmacogenomics and lung transplantation: clinical implications.
Burckart GJ, Hutchinson IV, Zeevi A. Burckart GJ, et al. Pharmacogenomics J. 2006 Sep-Oct;6(5):301-10. doi: 10.1038/sj.tpj.6500376. Epub 2006 Mar 7. Pharmacogenomics J. 2006. PMID: 16520825 Review. No abstract available.

See all similar articles

Cited by

Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT.
Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C, Ambrosetti M, Anker SD, Bayes-Genis A, Ben Gal T, Bowen TS, Cacciatore F, Caminiti G, Cavarretta E, Chioncel O, Coats AJS, Cohen-Solal A, D'Ascenzi F, de Pablo Zarzosa C, Gevaert AB, Gustafsson F, Kemps H, Hill L, Jaarsma T, Jankowska E, Joyce E, Krankel N, Lainscak M, Lund LH, Moura B, Nytrøen K, Osto E, Piepoli M, Potena L, Rakisheva A, Rosano G, Savarese G, Seferovic PM, Thompson DR, Thum T, Van Craenenbroeck EM. Simonenko M, et al. Transpl Int. 2024 Jun 19;37:13191. doi: 10.3389/ti.2024.13191. eCollection 2024. Transpl Int. 2024. PMID: 39015154 Free PMC article.
A Drug Safety Briefing (II) in Transplantation from Real-World Individual Pharmacotherapy Management to Prevent Patient and Graft from Polypharmacy Risks at the Very Earliest Stage.
Wolf U. Wolf U. Pharmaceuticals (Basel). 2024 Feb 25;17(3):294. doi: 10.3390/ph17030294. Pharmaceuticals (Basel). 2024. PMID: 38543080 Free PMC article. Review.
Metabolic Disorders in Liver Transplant Recipients: The State of the Art.
Gabrielli F, Golfieri L, Nascimbeni F, Andreone P, Gitto S. Gabrielli F, et al. J Clin Med. 2024 Feb 9;13(4):1014. doi: 10.3390/jcm13041014. J Clin Med. 2024. PMID: 38398327 Free PMC article. Review.
Dyslipidemia in Transplant Patients: Which Therapy?
Iannuzzo G, Cuomo G, Di Lorenzo A, Tripaldella M, Mallardo V, Iaccarino Idelson P, Sagnelli C, Sica A, Creta M, Baltar J, Crocetto F, Bresciani A, Gentile M, Calogero A, Giallauria F. Iannuzzo G, et al. J Clin Med. 2022 Jul 14;11(14):4080. doi: 10.3390/jcm11144080. J Clin Med. 2022. PMID: 35887846 Free PMC article. Review.
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients.
Cuomo G, Cioffi G, Di Lorenzo A, Iannone FP, Cudemo G, Iannicelli AM, Pacileo M, D'Andrea A, Vigorito C, Iannuzzo G, Giallauria F. Cuomo G, et al. J Clin Med. 2022 Jun 6;11(11):3247. doi: 10.3390/jcm11113247. J Clin Med. 2022. PMID: 35683632 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information